Presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise, as well as contributions from recognized experts in CAD, medical information technology systems, regulatory procedure, x-ray standards development, and clinical trial design. These expert contributors discuss the current state of the art and provide a road map for directing further research in lung cancer as well as other organ systems.
DETTAGLI PRODOTTO torna su
Titolo: Quantitative Imaging Tools for Lung Cancer Drug Assessment
Autori: Mulshine - Baer
Finitura: Copertina rigida